CeriBell Stock Forecast
NASDAQ: CBLLHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
Market open · Delayed 15 min · as of Oct 8, 9:43 AM ET
CBLL analyst consensus
Consensus (8 analysts)
strong_buy
Avg. price target
$28.57+24.22%
- Strong buy 1
- Buy 7
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 8 Wall Street analysts covering CeriBell (2026-10-08), 8 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $28.57, with a high estimate of $33.00 and a low estimate of $24.00. The average target implies upside of 24.2% from the current price of $23.00.
The spread between the highest and lowest targets is 37.5%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for CBLL.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 13% |
| Buy | 7 | 88% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $24.00 | +4.35% |
| Average target | $28.57 | +24.22% |
| High target | $33.00 | +43.48% |